E1	Condition:T1 Name:T30
E3	Condition:T3 Name:T32
E4	Eq-Comparison:T4 Value:T33 Operator:T34 Value:T35 Temporal-Unit:T37
E5	Observation:T5 Name:T36 Numeric-Filter:E4
E8	Modifier:T8 Modifies:T41
E9	Condition:T9 Name:T41
E12	Condition:T12 Name:T44
E13	Condition:T13 Name:T45
E14	Eq-Comparison:T14 Operator:T46 Value:T47 Temporal-Unit:T49
E15	Observation:T15 Name:T48 Numeric-Filter:E14
E17	Eq-Comparison:T17 Temporal-Period:T51
E19	Procedure:T19 Name:T16 Temporality:E17
E20	Condition:T20 Name:T53
E21	Eq-Comparison:T21 Operator:T55
E22	Condition:T22 Name:T56 Minimum-Count:E21
E23	Eq-Comparison:T23 Temporal-Period:T58
E24	Drug:T24 Name:T59 Temporality:E23
E26	Assertion:T26 Asserted:E18
E27	Coreference:T27 Refers-To:E24
E6	Eq-Comparison:T6 Value:T38 Temporal-Unit:T39 Operator:T40
E7	Age:T7 Numeric-Filter:E6
E11	Modifier:T11 Modifies:T44
E16	Modifier:T18 Modifies:T59
E18	Negation:T52 Negates:E27
E28	Drug:T28 Name:T29
E29	Modifier:T60 Modifies:T29
E31	Exception:T61 From:E24 Except:E28
T1	Condition 25 33	Pregnant
T3	Condition 64 67	GDM
T4	Eq-Comparison 73 83	13 to 32.6
T5	Observation 84 95	gestational
T8	Modifier 135 144	Singleton
T9	Condition 145 154	pregnancy
T12	Condition 207 224	diabetes mellitus
T13	Condition 230 233	GDM
T14	Eq-Comparison 244 248	≥ 33
T15	Observation 249 260	gestational
T17	Eq-Comparison 278 283	using
T19	Procedure 284 320	prophylactic antimicrobial treatment
T20	Condition 326 343	Immunocompromised
T21	Eq-Comparison 355 363	Multiple
T22	Condition 364 373	pregnancy
T23	Eq-Comparison 385 391	taking
T24	Drug 397 415	probiotic products
T26	Assertion 420 429	refuse to
T27	Coreference 435 450	the consumption
T30	Condition-Name 25 33	Pregnant
T31	Life-Stage-And-Gender 34 39	women
T32	Condition-Name 64 67	GDM
T33	Eq-Value 73 75	13
T34	Eq-Operator 76 78	to
T35	Eq-Value 79 83	32.6
T36	Observation-Name 84 95	gestational
T37	Eq-Temporal-Unit 96 101	weeks
T38	Eq-Value 107 109	18
T39	Eq-Temporal-Unit 110 115	years
T40	Eq-Operator 120 129	and older
T41	Condition-Name 145 154	pregnancy
T42	Life-Stage-And-Gender 180 185	Women
T44	Condition-Name 207 224	diabetes mellitus
T45	Condition-Name 230 233	GDM
T46	Eq-Operator 244 245	≥
T47	Eq-Value 246 248	33
T48	Observation-Name 249 260	gestational
T49	Eq-Temporal-Unit 261 266	weeks
T50	Life-Stage-And-Gender 272 277	Women
T51	Eq-Temporal-Period 278 283	using
T53	Condition-Name 326 343	Immunocompromised
T54	Life-Stage-And-Gender 344 349	women
T55	Eq-Operator 355 363	Multiple
T56	Condition-Name 364 373	pregnancy
T57	Life-Stage-And-Gender 379 384	Women
T58	Eq-Temporal-Period 385 391	taking
T59	Drug-Name 397 415	probiotic products
T6	Eq-Comparison 107 129	18 years old and older
T7	Age 124 129	older
T11	Modifier 191 206	pre-gestational
T16	Procedure-Name 284 320	prophylactic antimicrobial treatment
T18	Modifier 392 396	oral
T52	Negation 430 434	stop
T28	Drug 468 478	probiotics
T29	Drug-Name 468 478	probiotics
T60	Modifier 452 467	food-containing
T61	Exception 482 496	not considered
A1	Assertion-Type-Value E26 hypothetical
A2	Life-Stage-And-Gender-Type T31 female
A3	Eq-Operator-Value T34 BETWEEN
A4	Eq-Temporal-Unit-Value T37 week
A5	Eq-Temporal-Unit-Value T39 year
A6	Eq-Operator-Value T40 GTEQ
A7	Life-Stage-And-Gender-Type T42 female
A9	Eq-Operator-Value T46 GTEQ
A10	Eq-Temporal-Unit-Value T49 week
A11	Life-Stage-And-Gender-Type T50 female
A12	Eq-Temporal-Period-Value T51 present
A13	Life-Stage-And-Gender-Type T54 female
A14	Eq-Operator-Value T55 GT
A15	Life-Stage-And-Gender-Type T57 female
A16	Eq-Temporal-Period-Value T58 present
A17	Observation-Type-Value E5 measurement
A18	Observation-Type-Value E15 measurement
R1	If-Then Arg1:T50 Arg2:E19
R2	If-Then Arg1:E20 Arg2:T54
R3	If-Then Arg1:T57 Arg2:E24
R4	And Arg1:T31 Arg2:E3
R5	And Arg1:T42 Arg2:E12
R6	And Arg1:E24 Arg2:E26
R7	During Arg1:E3 Arg2:E5
